Protagonist Therapeutics, Inc.PTGXNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$182.80M
↑ 683% above average
Average (9y)
$-31.38M
Historical baseline
Range
High:$182.80M
Low:$-108.97M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $182.80M | +358.0% |
| 2023 | $-70.84M | +35.0% |
| 2022 | $-108.93M | +0.0% |
| 2021 | $-108.97M | -49.4% |
| 2020 | $-72.95M | -71.7% |
| 2019 | $-42.49M | +15.7% |
| 2018 | $-50.43M | -1673.1% |
| 2017 | $3.21M | +110.6% |
| 2016 | $-30.35M | -105.3% |
| 2015 | $-14.78M | - |